For citations:
Radygina T.V., Kuptsova D.G., Illarionov A.S., Anushenko A.O., Kurbatova O.V., Potapov A.S., Semikina E.L., Petrichuk S.V., Fisenko A.P. DETERMINATION OF THE RESIDUAL LEVEL OF ADALIMUMAB TO ASSESS THE EFFECTIVENESS OF ANTI-TNF THERAPY IN CHILDREN WITH INFLAMMATORY BOWEL DISEASES. Russian Pediatric Journal. 2022;25(4):281. (In Russ.)
Email this article 